10/07/2024 | Press release | Distributed by Public on 10/07/2024 14:56
| | |
Per share
|
| |
Total
|
| ||||||
Public offering price | | | | $ | | | | | $ | | | ||
Underwriting discounts and commissions(1) | | | | $ | | | | | $ | | | ||
Proceeds, before expenses, to us | | | | $ | | | | | $ | | | |
| | |
Page
|
| |||
About This Prospectus Supplement
|
| | | | S-ii | | |
Prospectus Supplement Summary
|
| | | | S-1 | | |
The Offering
|
| | | | S-7 | | |
Risk Factors
|
| | | | S-9 | | |
Cautionary Statement Regarding Forward-Looking Statements
|
| | | | S-11 | | |
Use of Proceeds
|
| | | | S-13 | | |
Dividend Policy
|
| | | | S-14 | | |
Dilution | | | | | S-15 | | |
Description of Securities Offered
|
| | | | S-17 | | |
CertainU.S.Federal Income Tax Considerations
|
| | | | S-18 | | |
Underwriting | | | | | S-23 | | |
Legal Matters
|
| | | | S-34 | | |
Experts | | | | | S-34 | | |
Where You Can Find More Information
|
| | | | S-34 | | |
Incorporation of Certain Information by Reference
|
| | | | S-34 | | |
| | |
Page
|
| |||
About this Prospectus
|
| | | | 1 | | |
Risk Factors
|
| | | | 2 | | |
Cautionary Statement Regarding Forward-Looking Statements
|
| | | | 3 | | |
The Company
|
| | | | 5 | | |
Use of Proceeds
|
| | | | 8 | | |
Securities We May Offer and/or Selling Stockholders May Offer Or Sell
|
| | | | 9 | | |
Description of Capital Stock
|
| | | | 10 | | |
Description of Debt Securities
|
| | | | 20 | | |
Description of Warrants
|
| | | | 34 | | |
Description of Units
|
| | | | 36 | | |
Plan of Distribution
|
| | | | 39 | | |
Legal Matters
|
| | | | 42 | | |
Experts
|
| | | | 42 | | |
Where You Can Find More Information
|
| | | | 42 | | |
Incorporation by Reference
|
| | | | 43 | | |
|
Public offering price per share
|
| | | | | | | | | $ | | | |
|
Historical net tangible book value per share as of June 30, 2024
|
| | | $ | 1.67 | | | | | | | | |
|
Increase in net tangible book value per share attributable to this offering
|
| | | | | | | | | | | | |
|
As adjusted net tangible book value per share after giving effect to this offering
|
| | | | | | | | | | | | |
|
Dilution per share to investors participating in this offering
|
| | | | | | | | | $ | | | |
Name
|
| |
Number of
shares |
|
J.P. Morgan Securities LLC
|
| | | |
Jefferies LLC
|
| | | |
Piper Sandler & Co.
|
| | | |
BMO Capital Markets Corp.
|
| | | |
Wedbush Securities Inc.
|
| | | |
Raymond James & Associates, Inc.
|
| | | |
Total:
|
| | | |
| | |
Without
exercise of option to purchase additional shares |
| |
With full
exercise of option to purchase additional shares |
| |||
Per share
|
| | | $ | | | | | | |
Total
|
| | | $ | | | | | |
| | |
Page
|
| |||
About this Prospectus
|
| | | | 1 | | |
Risk Factors
|
| | | | 2 | | |
Cautionary Statement Regarding Forward-Looking Statements
|
| | | | 3 | | |
The Company
|
| | | | 5 | | |
Use of Proceeds
|
| | | | 8 | | |
Securities We May Offer and/or Selling Stockholders May Offer Or Sell
|
| | | | 9 | | |
Description of Capital Stock
|
| | | | 10 | | |
Description of Debt Securities
|
| | | | 20 | | |
Description of Warrants
|
| | | | 34 | | |
Description of Units
|
| | | | 36 | | |
Plan of Distribution
|
| | | | 39 | | |
Legal Matters
|
| | | | 42 | | |
Experts
|
| | | | 42 | | |
Where You Can Find More Information
|
| | | | 42 | | |
Incorporation by Reference
|
| | | | 43 | | |
| J.P. Morgan | | |
Jefferies
|
| |
Piper Sandler
|
|
| BMO Capital Markets | | |
Wedbush PacGrow
|
| |
Raymond James
|
|